UGT2A3 and inflammatory bowel disease: Future research priorities should focus on comprehensive mechanistic characterization of CHAD and UGT2A3, whose IBD roles remain incompletely understood despite robust diagnostic performance, through targeted functional studies investigating CHAD’s roles in epithelial cell adhesion and barrier integrity, and UGT2A3’s functions in xenobiotic metabolism and epithelial homeostasis.